Last updated on May 2018

Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases


Brief description of study

The hypothesis for this study is that a preparative regimen that maximizes host immunosuppression without myeloablation will be well tolerated and sufficient for engraftment of donor hematopoietic cells. It is also to determine major toxicities from these conditioning regimens, within the first 100 days after transplantation.

Clinical Study Identifier: NCT00920972

Find a site near you

Start Over

St. Louis University

Saint Louis, MO United States
1.42miles
  Connect »